🇯🇵 Hunterase in Japan

PMDA authorised Hunterase on 22 January 2021

Marketing authorisation

PMDA — authorised 22 January 2021

  • Marketing authorisation holder: CLINIGEN K.K.
  • Status: approved

Hunterase in other countries

Same drug, different regulators. Each page below lists the local marketing authorisation, HTA position, pricing, and adverse-event data.

Other Metabolic approved in Japan

Frequently asked questions

Is Hunterase approved in Japan?

Yes. PMDA authorised it on 22 January 2021.

Who is the marketing authorisation holder for Hunterase in Japan?

CLINIGEN K.K. holds the Japanese marketing authorisation.